# Efficacy of Intrathecal Administration of Budesonide to Prevent Bronchopulmonary Dysplasia

> **NCT07725575** · PHASE4 · COMPLETED · sponsor: **Universitas Indonesia** · enrollment: 86 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia (BPD)

## Interventions

- **DRUG:** Experimental

## Key facts

- **NCT ID:** NCT07725575
- **Lead sponsor:** Universitas Indonesia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-01
- **Primary completion:** 2025-04-24
- **Final completion:** 2025-06-01
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2026-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07725575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07725575, "Efficacy of Intrathecal Administration of Budesonide to Prevent Bronchopulmonary Dysplasia". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07725575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*